Weight Loss Via Bariatric Surgery and Lifestyle Modification

Sponsor
King Saud University (Other)
Overall Status
Completed
CT.gov ID
NCT05775172
Collaborator
King AbdulAziz City for Science and Technology (Other)
79
1
15.3
5.2

Study Details

Study Description

Brief Summary

Gastric myoelectric, inflammatory, and hormonal responses, body compositional, energy expenditure, and metabolic changes during the development of obesity and the weight loss process are underinvestigated. This project studied the myoelectrical inflammatory and hormonal responses of the stomach, in addition to energy expenditure and body composition changes during weight loss via bariatric surgery and lifestyle intervention.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Sleeve gastrectomy
  • Dietary Supplement: Lifestyle intervention
  • Other: Control

Detailed Description

Gastric myoelectric, inflammatory, and hormonal responses, body compositional, energy expenditure, and metabolic changes during the development of obesity and the weight loss process are underinvestigated. This project studied the myoelectrical, inflammatory, and hormonal responses of the stomach, in addition to energy expenditure and body composition changes during weight loss via bariatric surgery and lifestyle intervention.

Methods: We recruited 79 participants who were assigned to three groups: bariatric surgery (BS group n=27), lifestyle intervention (LS group, n=22), and waitlist control (C group n=30). For all participants, electrogastrography, inflammatory cytokines, gastric hormones analysis, body composition analysis, energy expenditure, and dietary assessment were done at baseline and at 6 months.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
79 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Gastric Myoelectric Activity, Inflammatory, Dietary, and Body Composition Changes During Weight Loss Via Bariatric Surgery and Lifestyle Modification
Actual Study Start Date :
Jun 1, 2021
Actual Primary Completion Date :
Jun 30, 2022
Actual Study Completion Date :
Sep 10, 2022

Arms and Interventions

Arm Intervention/Treatment
Waitlist control

Waitlist control (C group n=30) did not achieve any significant weight loss and did not follow lifestyle intervention

Other: Control
No interventions were applied

Lifestyle intervention

Lifestyle intervention (LS group, n=22) follows multimodal lifestyle intervention in form of 500-100 kcal deficit , gradual physical activity and some behavioral modifications

Dietary Supplement: Lifestyle intervention
balanced 500 to 1000-calorie-deficit diet, personalized physical activity plan, and customized behavioral modification

Bariatric surgery

Bariatric surgery (BS group n=27) undergoes laparoscopic sleeve gastrectomy

Procedure: Sleeve gastrectomy
laparoscopic sleeve gastrectomy was done under general anesthesia by the same surgeon in the SBAHC. Routine preoperative, and postoperative care (including early post-operative dietary management) were done. Baseline assessment was taken within the last week before the surgery during the preoperative preparation and the final assessment was recorded 6 months after the surgery date.

Outcome Measures

Primary Outcome Measures

  1. Gastric myoelectric activity [6 months]

    The gastric myoelectric activity was measured in fasting (for 10 mins) and post-prandial state (for 30 mins) using a multichannel electrogastrography (EGG) with a water load satiety test

  2. Inflammatory changes [6 months]

    Serum levels of inflammatory markers involving interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), C-reactive protein (CRP), and monocyte chemoattractant protein (MCP-1),

  3. Body composition measurement [6 MONTHS]

    Body composition was analyzed via a multi-Frequency segmental bioelectric impedance analysis monitor

  4. Resting Energy Expenditure [6 MONTHS]

    Resting metabolic rate (RMR) was measured by the automated metabolic cart indirect calorimetry (IC) using a standard canopy hood

  5. hormonal analysis [6 Months]

    serum levels of ghrelin, gastrin, and irisin (ELISA kits MyBiosource, San Diego, CA, USA; Catalog numbers: MBS2700428, MBS264399, MBS2600406, respectively).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • BMI > 35 kg/m2,

  • Being free of any acute medical condition, inflammatory conditions, malignancy, or psychiatric disorders

Exclusion Criteria:
  • Taking weight-losing pharmacotherapy

  • Who underwent previous bariatric surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 College of Applied Medical Sciences Riyadh Saudi Arabia 11433

Sponsors and Collaborators

  • King Saud University
  • King AbdulAziz City for Science and Technology

Investigators

  • Principal Investigator: Mahmoud Abulmeaty, King Saud University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mahmoud Abulmeaty, M.D., FACN., Professor, King Saud University
ClinicalTrials.gov Identifier:
NCT05775172
Other Study ID Numbers:
  • BSvsLS
First Posted:
Mar 20, 2023
Last Update Posted:
Mar 20, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Mahmoud Abulmeaty, M.D., FACN., Professor, King Saud University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 20, 2023